Clinical Trials Directory

Trials / Completed

CompletedNCT01516658

HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study

Efficacy of Hydrogel Coil on Endovascular Treatment for Intracranial Aneurysms; Multi-center, Prospective, Randomized, Open-label Blind-endpoint Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
431 (actual)
Sponsor
Kobe City General Hospital · Academic / Other
Sex
All
Age
20 Years – 79 Years
Healthy volunteers
Not accepted

Summary

HYBRID study is prospective randomized open label controlled multi center trial, to compare Hydrocoil and bare platinum coil for recanalization after endovascular treatment of intracranial aneurysms.

Detailed description

At least one Hydrocoil have to use in Hydrocoil arm, and only bare platinum coil have to use in Control arm. Primary endpoint is recanalization within 1 year after embolization, and secondary endpoint are: 1. aneurysmal rupture within 1 year after embolization 2. any event within 30 days after embolization 3. recanalization within 6 months after embolization 4. aneurysmal retreatment within 1 year after embolization 5. aneurysmal rupture and any death within 1 year after embolization 6. any stroke within 1 year after embolization 7. any stroke, death hemorrhagic event, aneurysmal recanalization or retreatment within 1 year after embolization 8. change in aneurysmal occlusion 9. any comlicaion within 1 year after embolization 10. %length of Hydrocoil, maximum diameter of aneurysm, volume embolization ratio.

Conditions

Interventions

TypeNameDescription
DEVICEHydrogel coilat least one Hydrogel coil have to use for embolization
DEVICEBare platinum coilonly bare platinum coil have to use for embolization

Timeline

Start date
2012-06-01
Primary completion
2018-03-01
Completion
2019-06-01
First posted
2012-01-25
Last updated
2019-10-16

Locations

2 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT01516658. Inclusion in this directory is not an endorsement.